Advertisement Our innovative Tool HyperSuite®: EDC, Data Management and a variety of innovative e-Clinical Trial Solutions on ONE unique Platform - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
More info about Pierrel Research

Our innovative Tool HyperSuite®: EDC, Data Management and a variety of innovative e-Clinical Trial Solutions on ONE unique Platform

The Pierrel Research CTT team has both, the enthusiasm and the practical experience to deal with the different challenges they are confronted with by the different phases of a specific project. For each task assigned to them, it is the main goal of our CTT team to understand the needs of our clients, to bring these ideas to life – and thus to provide the highest level of confidence in our abilities to deliver operational success on time and within budget.

Based on our experience with CTT and innovative techniques, considering the technologic development in the last few years as well as its current success in R&D, we recommend to use one unique EDC and Data Management System, like HyperSuite®, best already from the very beginning within the whole drug development program. Nowadays, with the huge pressure of competition on the market, with the clear need on high quality data collection as well as real time data review (especially for expedite safety reporting), the use of modern ECD solutions became a clear "must".

HyperSuite® is a web-based e-Study Management Solution: it can be accessed from everywhere on the globe, and it is independent from the type of hardware in use. The birth of HyperSuite®, goes back to end of the 1990s when our partner CINECA (one of the largest European supercomputing centers) established the basis of a commercial, technological and scientific adventure.

At that time, only a few people in the life science environment were fully convinced that the web was the future of multicentre clinical trials- but Pierrel Research accepted this challenge and brought HyperSuite® to market.

Up today, HyperSuite®, has been used in more than 320 studies, conducted in 40 countries, involving 18.186 investigators and recruiting 310.216 patients.